» Articles » PMID: 24573880

TSLP Signaling Pathway Map: a Platform for Analysis of TSLP-mediated Signaling

Overview
Specialty Biology
Date 2014 Feb 28
PMID 24573880
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Thymic stromal lymphopoietin (TSLP) is a four-helix bundle cytokine that plays a critical role in the regulation of immune responses and in the differentiation of hematopoietic cells. TSLP signals through a heterodimeric receptor complex consisting of an interleukin-7 receptor α chain and a unique TSLP receptor (TSLPR) [also known as cytokine receptor-like factor 2 (CRLF2)]. Cellular targets of TSLP include dendritic cells, B cells, mast cells, regulatory T (Treg) cells and CD4+ and CD8+ T cells. The TSLP/TSLPR axis can activate multiple signaling transduction pathways including the JAK/STAT pathway and the PI-3 kinase pathway. Aberrant TSLP/TSLPR signaling has been associated with a variety of human diseases including asthma, atopic dermatitis, nasal polyposis, inflammatory bowel disease, eosinophilic eosophagitis and, most recently, acute lymphoblastic leukemia. A centralized resource of the TSLP signaling pathway cataloging signaling events is not yet available. In this study, we present a literature-annotated resource of reactions in the TSLP signaling pathway. This pathway map is publicly available through NetPath (http://www.netpath.org/), an open access signal transduction pathway resource developed previously by our group. This map includes 236 molecules and 252 reactions that are involved in TSLP/TSLPR signaling pathway. We expect that the TSLP signaling pathway map will provide a rich resource to study the biology of this important cytokine as well as to identify novel therapeutic targets for diseases associated with dysregulated TSLP/TSLPR signaling. Database URL: http://www.netpath.org/pathways?path_id=NetPath_24.

Citing Articles

A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases.

Shi L, Yu M, Jin Y, Chen P, Mu G, Tam S Front Immunol. 2024; 15:1442588.

PMID: 39726595 PMC: 11670205. DOI: 10.3389/fimmu.2024.1442588.


The Role of the JAK-STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia.

Zietara K, Wroblewska K, Zajaczkowska M, Taczala J, Lejman M Int J Mol Sci. 2024; 25(13).

PMID: 38999955 PMC: 11241568. DOI: 10.3390/ijms25136844.


Weighted Breaths: Exploring Biologic and Non-Biologic Therapies for Co-Existing Asthma and Obesity.

Pilkington 4th A, Buragamadagu B, Johnston R Curr Allergy Asthma Rep. 2024; 24(7):381-393.

PMID: 38878250 PMC: 11233394. DOI: 10.1007/s11882-024-01153-x.


Disrupting TSLP-TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases.

Adhikary P, Idowu T, Tan Z, Hoang C, Shanta S, Dumbani M EMBO Mol Med. 2024; 16(7):1630-1656.

PMID: 38877290 PMC: 11250841. DOI: 10.1038/s44321-024-00085-3.


Thymic Stromal Lymphopoietin Activates Mouse Dendritic Cells Through the JAK/SYK Pathway in Promoting Th17 Response in Psoriasis.

Song C, Sun J, Zhao Z, Zhang X, Ding X, Liang X Balkan Med J. 2024; 41(3):174-185.

PMID: 38700313 PMC: 11077931. DOI: 10.4274/balkanmedj.galenos.2024.2024-1-96.


References
1.
Orchard S, Kerrien S . Molecular interactions and data standardisation. Methods Mol Biol. 2009; 604:309-18. DOI: 10.1007/978-1-60761-444-9_21. View

2.
Isaksen D, Baumann H, Trobridge P, Farr A, Levin S, Ziegler S . Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol. 1999; 163(11):5971-7. View

3.
Tsai A, Yoda A, Weinstock D, Lieber M . t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not. Blood. 2010; 116(11):1993-4. PMC: 5773278. DOI: 10.1182/blood-2010-05-286492. View

4.
Tasian S, Doral M, Borowitz M, Wood B, Chen I, Harvey R . Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood. 2012; 120(4):833-42. PMC: 3412346. DOI: 10.1182/blood-2011-12-389932. View

5.
Levin S, Koelling R, Friend S, Isaksen D, Ziegler S, Perlmutter R . Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol. 1999; 162(2):677-83. View